Abstract:Aims/Purpose: To evaluate molecules involved in oxidative stress (OS), inflammation, angiogenesis, and apoptosis, and discern which of these are more implicated in diabetic retinopathy (DR) and diabetic macular edema (DME) by investigating the correlation between them in the plasma (PLS) and vitreous humour (VIT), and examining data obtained from ophthalmological examinations. Methods: Type 2 diabetic (T2DM) patients with DR/DME (DRG/DMEG n = 112) and non‐DM subjects as the surrogate controls (SCG n = 48) were selected. Blood samples were processed to determine the glycaemic and lipid profiles, C reactive protein, malondialdehyde (MDA), 4‐hydroxynonenal (4HNE), superoxide dismutase (SOD), catalase (CAT) levels and total antioxidant capacity (TAC). In addition, interleukin 6 (IL6), vascular endothelial growth factor (VEGF), and caspase 3 were assayed. The VIT samples were collected to measure the expression levels of all the above‐mentioned molecules. Results: Our findings support the presence of molecules involved in OS, inflammation, angiogenesis, and apoptosis in the PLS and VIT samples from T2DM. In PLS from DRG, there was a decrease in the antioxidant load and an increase in pro‐angiogenic molecules, but an increase in pro‐oxidants and a decline in antioxidants intravitreally. In PLS from DMEG, pro‐oxidants and pro‐inflammatory molecules were augmented and the antioxidant capacity diminished, but the pro‐oxidants increased, and antioxidants decreased intravitreally. Furthermore, we found a positive correlation between the PLS‐CAT and the VIT‐SOD levels in DRG, and a negative correlation between the PSD‐4HNE and the VIT‐TAC levels in DMEG. Conclusions: We conclude that hyperglycaemia induces anomalies in biochemical pathways with crosstalk between them; MDA, 4HNE, TAC, VEGF, and IL6 are promoters of the clinical manifestations of PDR and DME. The above molecules have been selected as biomarker candidates for distinguishing T2DM patients at risk of DR, DME and vision loss.

Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy

Bioactive lipids in pathological retinopathy.

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies

Oxidative Stress: Implications for the Development of Diabetic Retinopathy and Antioxidant Therapeutic Perspectives

Oxidative Stress and Its Regulation in Diabetic Retinopathy

Molecular mechanisms of diabetic retinopathy: Potential therapeutic targets

The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy

Roles of Reactive Oxygen Species in Vascular Complications of Diabetes: Therapeutic Properties of Medicinal Plants and Food

Molecular mechanisms of ROS production and oxidative stress in diabetes

Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease—Interplay Between Inflammation and Oxidative Stress

Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions

The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects

Diabetic Retinopathy, Superoxide Damage and Antioxidants.

The Concomitance of Hypertension and Diabetes Exacerbating Retinopathy: The Role of Inflammation and Oxidative Stress.

New Insights on Dietary Polyphenols for the Management of Oxidative Stress and Neuroinflammation in Diabetic Retinopathy

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target

Evaluation of Ocular and Systemic Oxidative Stress Markers in Patients with Diabetic Retinopathy

Crosstalk between oxidative stress, inflammation, angiogenesis and apoptosis in diabetic macular edema